Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations

References

• Cheng L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001;410:37–40.
   PubMed Web of Science ®Google Scholar
• Keshet Y, Seger R. The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol 2010;661:3–38.
   PubMedGoogle Scholar
• Rincon M, Davis RJ. Regulation of the immune response by stress-activated protein kinases. Immunol Rev 2009;228:212–24.
   PubMed Web of Science ®Google Scholar
• Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 2010;90:1507–46.
   PubMed Web of Science ®Google Scholar
• Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Genet Dev 2002;12:14–21.
   PubMed Web of Science ®Google Scholar
• Derijard B, Hibi M, Wu LH, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;76:1025–37.
   PubMed Web of Science ®Google Scholar
• Kyriakis JM, Avruch J. pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine. J Biol Chem 1990;265:17355–63.
   PubMed Web of Science ®Google Scholar
• Kyriakis JM, Brautigan DL, Ingebritsen TS, Avruch J. pp54 microtubule-associatedprotein-2 kinase requires both tyrosine and serine/threonine phosphorylation for activity. J Biol Chem 1991;266:10043–6.
   PubMed Web of Science ®Google Scholar
• Kyriakis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994;369:156–60.
   PubMed Web of Science ®Google Scholar
• Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103:239–52.
   PubMed Web of Science ®Google Scholar
• Holland PM, Suzanne M, Campbell JS, et al. MKK7 is a stress-activated mitogen-activated protein kinase functionally related to hemipterous. J Biol Chem 1997;272:24994–8.
   PubMed Web of Science ®Google Scholar
• Tournier C, Whitmarsh AJ, Cavanagh J, et al. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc Natl Acad Sci 1997;94:7337–42.
   PubMed Web of Science ®Google Scholar
• Moriguchi T, Toyoshima F, Masuyama N, et al. A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses. Embo J 1997;16:7045–53.
   PubMed Web of Science ®Google Scholar
• Yao Z, Diener K, Wang XS, et al. Activation of stress-activated protein kinases/c-Jun N-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase kinase. J Biol Chem 1997;272:32378–83.
   PubMed Web of Science ®Google Scholar
• Wu Z, Wu J, Jacinto E, Karin M. Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase. Mol Cell Biol 1997;17:7407–16.
   PubMed Web of Science ®Google Scholar
• Lu X, Nemoto S, Lin A. Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38. J Biol Chem 1997;272:24751–4.
   PubMed Web of Science ®Google Scholar
• Dai T, Rubie E, Franklin CC, et al. Stress-activated protein kinases bind directly to the delta domain of c-Jun in resting cells: implications for repression of c-Jun function. Oncogene 1995;10:849–55.
   PubMed Web of Science ®Google Scholar
• Kallunki T, Su B, Tsigelny I, et al. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 1994;8:2996–3007.
   PubMed Web of Science ®Google Scholar
• Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Cell Biol 2007;19:142–9.
   PubMed Web of Science ®Google Scholar
• Asaoka Y, Nishina H. Diverse physiological functions of MKK4 and MKK7 during early embryogenesis. J Biochem 2010;148:393–401.
   PubMed Web of Science ®Google Scholar
• Manning AM, Davis RJ. Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2003;2:554–65.
   PubMed Web of Science ®Google Scholar
• Hess P, Pihan G, Sawyers CL, et al. Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat Genet 2002;32:201–5.
   PubMed Web of Science ®Google Scholar
• Cellurale C, Sabio G, Kennedy NJ, et al. Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation. Mol Cell Biol 2011;31:1565–76.
   PubMed Web of Science ®Google Scholar
• Hui L, Zatloukal K, Scheuch H, et al. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest 2008;118:3943–53.
   PubMed Web of Science ®Google Scholar
• Das M, Garlick DS, Greiner DL, Davis RJ. The role of JNK in the development of hepatocellular carcinoma. Genes Dev 2011;25:634–45.
   PubMed Web of Science ®Google Scholar
• Sakurai T, Maeda S, Chang L, Karin M. Loss of hepatic NF-kappa B activity enhances chemical hepato carcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci 2006;103:10544–51.
   PubMed Web of Science ®Google Scholar
• Chen N, Nomura M, She QB, et al. Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res 2001;61:3908–12.
   PubMed Web of Science ®Google Scholar
• LoGrasso P, Kamenecka T. Inhibitors of c-jun-N-terminal kinase (JNK). Mini Rev Med Chem 2008;8:755–66.
   PubMed Web of Science ®Google Scholar
• Bennett BL, Sasaki DT, Murray BW, et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001;98:13681–6.
   PubMed Web of Science ®Google Scholar
• Bain J, Plater L, Elliott M, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J 2007;408:297–315.
   PubMed Web of Science ®Google Scholar
• Iñesta-Vaquera FA, Campbell DG, Arthur JS, Cuenda A. ERK5 pathway regulates the phosphorylation of tumour suppressor hDlg during mitosis. Biochem Biophys Res Commun 2010;399:84–90.
   PubMed Web of Science ®Google Scholar
• Gaillard P, Jeanclaude-Etter I, Ardissone V, et al. Design and synthesis of the first generation of novel potent, selective and in vivo active (benzothiazol-2-yl) acetonitrile inhibitors of the c-Jun N-terminal kinase. J Med Chem 2005;48:4596–607.
   PubMed Web of Science ®Google Scholar
• Zhang T, Inesta-Vaquera F, Niepel M, et al. Discovery of potent and selective covalent inhibitors of JNK. Chem Biol 2012;19:140–54.
   PubMed Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res 2000;28:235–42.
   PubMed Web of Science ®Google Scholar
• Suvannang N, Nantasenamat C, Isarankura-Na-Ayudhya C, Prachayasittikul V. Molecular docking of aromatase inhibitors. Molecules 2011;16:3597–617.
   Web of Science ®Google Scholar
• De Beer TA, Berka K, Thornton JM, Laskowski RA. PDBsum additions. Nucleic Acids Res 2014;42:D292–6. (Database issue):
   Google Scholar
• Chen J, Lai L. Pocket v.2: further developments on receptor-based pharmacophore modeling. J Chem Inf Model 2006;46:2684–91.
   PubMed Web of Science ®Google Scholar
• Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004;47:1739–49.
   PubMed Web of Science ®Google Scholar
• Palakurti R, Sriram D, Yogeswari P, Vadrevu R. Multiple e-pharmacophore modeling combined with high-throughput virtual screening and docking to identify potential inhibitors of β-Secretase (BACE1). Mol Inform 2013;32:385–98.
   PubMed Web of Science ®Google Scholar
• Pradeep N, Munikumar M, Swargam S, et al. Combination of e-pharmacophore modeling, multiple docking strategies and molecular dynamic simulations to discover of novel antagonists of BACE1. Biomol Struct Dyn 2015;33:129–30.
   PubMed Web of Science ®Google Scholar
• Toledo Warshaviak D, Golan G, Borrelli KW, et al. Structure-based virtual screening approach for discovery of covalently bound ligands. J Chem Inf Model 2014;54:1941–50.
   PubMed Web of Science ®Google Scholar
• Priyadarshini V, Pradhan D, Munikumar M, et al. Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis. J Biomol Struct Dyn 2014;32:876–89.
   PubMed Web of Science ®Google Scholar
• Carrieri A, Pérez-Nueno VI, Fano A, et al. Biological profiling of anti-HIV agents and insight into CCR5 antagonist binding using in silico techniques. Chem Med Chem 2009;4:1153–63.
   Web of Science ®Google Scholar
• Kirchmair J, Distinto S, Markt P, et al. How to optimize shape-based virtual screening: choosing the right query and including chemical information. J Chem Inf Model 2009;49:678–92.
   PubMed Web of Science ®Google Scholar
• Pérez-Nueno VI, Pettersson S, Ritchie DW, et al. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening. J Chem Inf Model 2009;49:810–23.
   PubMed Web of Science ®Google Scholar
• Muthusamy K, Singh KD, Chinnasamy S, et al. High throughput virtual screening and E-pharmacophore filtering in the discovery of new BACE-1 inhibitors. Interdiscip Sci 2013;5:119–26.
   PubMed Web of Science ®Google Scholar
• Venkatraman V, Pérez-Nueno VI, Mavridis L, Ritchie DW. Comprehensive comparison of ligand-based virtual screening tools against the DUD data set reveals limitations of current 3D methods. J Chem Inf Model 2010;50:2079–93.
   PubMed Web of Science ®Google Scholar
• Maestro 9.8, New York: Schrödinger. Available at: http://www.schrodinger.com/
   Google Scholar
• Brooks WH, Daniel KG, Sung SS, Guida WC. Computational validation of the importance of absolute stereochemistry in virtual screening. J Chem Inf Model 2008;48:639–45.
   PubMed Web of Science ®Google Scholar
• Shelley JC, Cholleti A, Frye LL, et al. Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules. J Comput Aided Mol Des 2007;21:681–91.
   PubMed Web of Science ®Google Scholar
• Pradhan D, Priyadarshini V, Munikumar M, et al. Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study. J Biomol Struct Dyn 2014;32:171–85.
   PubMed Web of Science ®Google Scholar
• Du J, Sun H, Xi L, et al. Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation. J Comput Chem 2011;32:2800–9.
   PubMed Web of Science ®Google Scholar
• Lipinski C, Hopkins A. Navigating chemical space for biology and medicine. Nature 2004;432:855–61.
   PubMed Web of Science ®Google Scholar
• Friesner RA, Murphy RB, Repasky MP, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 2006;49:6177–96.
   PubMed Web of Science ®Google Scholar
• Cho AE, Guallar V, Berne BJ, Friesner R. Importance of accurate charges in molecular docking: quantum mechanical/molecular mechanical (QM/MM) approach. J Comput Chem 2005;26:915–31.
   PubMed Web of Science ®Google Scholar
• Cho AE, Rinaldo D. Extension of QM/MM docking and its applications to metalloproteins. J Comput Chem 2009;30:2609–16.
   PubMed Web of Science ®Google Scholar
• Wang H, Aslanian R, Madison VS. Induced-fit docking of mometasone furoate and further evidence for glucocorticoid receptor 17alpha pocket flexibility. J Mol Graph Model 2008;27:512–21.
   PubMed Web of Science ®Google Scholar
• Wu G, Vashishtha SC, Erve JCL. Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches to rationalize the site of conjugation for thiophene containing drugs. Chem Res Toxicol 2010;23:1393–404.
   PubMed Web of Science ®Google Scholar
• Klebe G, Kramer O, Sotriffer C. Strategies for the design of inhibitors of aldose reductase, an enzyme showing pronounced induced-fit adaptations. Cell Mol Life Sci 2004;61:783–93.
   PubMed Web of Science ®Google Scholar
• Umamaheswari A, Munikumar M, Pradhan D, Hemanth M. Docking studies towards exploring antiviral compounds against envelope protein of yellow fever virus. Interdiscip Sci 2011;3:64–77.
   PubMed Web of Science ®Google Scholar
• Amineni U, Pradhan D, Marisetty H. In silico identification of common putative drug targets in Leptospira interrogans. J Chem Biol 2010;3:165–73.
   PubMedGoogle Scholar
• Mobley DL, Dill KA. Binding of small-molecule ligands to proteins: “what you see; is not always ;what you get.” Structure 2009;17:489–98.
   PubMed Web of Science ®Google Scholar
• Lyne PD, Lamb ML, Saeh JC. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J Med Chem 2006;49:4805–8.
   PubMed Web of Science ®Google Scholar
• Das D, Koh Y, Tojo Y, et al. Prediction of potency of protease inhibitors using free energy simulations with polarizable quantum mechanics-based ligand charges and a hybrid water model. J Chem Inf Model 2009;49:2851–62.
   PubMed Web of Science ®Google Scholar
• Martyna GJ, Tobias DJ, Klein ML. Constant pressure molecular dynamics algorithms. J Chem Phys 1994;101:4177–89.
   Web of Science ®Google Scholar
• Tripathi SK, Muttineni R, Singh SK. Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors. J Theor Biol 2013;334:87–100.
   PubMed Web of Science ®Google Scholar
• Truchon JF, Bayly CI. Evaluating virtual screening methods: good and bad metrics for the “early recognition problem.” J Chem Inf Model 2007;47:488–508.
   PubMed Web of Science ®Google Scholar
• Haynes NE, Scott NR, Chen LC, et al. Identification of an adamantyl azaquinolone JNK selective Inhibitor. ACS Med Chem Lett 2012;3:764–8.
   PubMed Web of Science ®Google Scholar
• Barillari C, Taylor J, Viner R, Essex JW. Classification of water molecules in protein-binding sites. J Am Chem Soc 2007;129:2577–87.
   PubMed Web of Science ®Google Scholar